Samuel H. Willemse

Samuel H. Willemse

Auto-generated profile, based on publicly available information

Samuel H. Willemse

Department of Oral and Maxillofacial Surgery, Amsterdam UMC and Academic Center for Dentistry Amsterdam (ACTA) University of Amsterdam Amsterdam the Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
SWS.H. Willemse
S.H. Willemse
MOM.A.E.M. Oomens
M.A.E.M. Oomens
JLJ. De Lange
J. De Lange
LKL.H.E. Karssemakers
L.H.E. Karssemakers

17 December 2021 in The Cleft Palate Craniofacial Journal
Verified
Journal Article
Open access
PDF file
RPRoan L. M. Ploumen
Roan L. M. Ploumen
SWSamuel H. Willemse
Samuel H. Willemse
RJRonald E. G. Jonkman
Ronald E. G. Jonkman
JNJitske W. Nolte
Jitske W. Nolte
ABAlfred G Becking
Alfred G Becking
Measuring the impact of orthognathic surgery on quality of life is of significant importance in patients with cleft deformities. Standardized tools such as patient-reported outcome measures (PROMs) are needed to fully comprehend patients’ needs and perceptions. Therefore, the availability of reliable, valid, and comprehensive questionnaires for patients is essential. The aim of this study is to identify PROMs measuring the impact of orthognathic surgery on quality of life in patients with cleft deformities and to evaluate the identified PROMs. A systematic search of the literature was performed according to the preferred reporting items for systematic reviews and meta-analysis guidelines. All validated PROMs, regarding the impact of orthognathic surgery on quality of life in patients with cleft deformities, were identified and assessed according to the quality criteria proposed for measurement properties of health status questionnaires. An electronic search yielded 577 articles. After a full-text review of 87 articles, 4 articles met the inclusion criteria, comprising 58 PROMs. Of these 58 PROMs, 1 PROM (the CLEFT-Q) has been validated to measure the impact of orthognathic surgery on patients with a facial cleft. Evaluation of methodological quality of the included articles and assessment of the measurement properties of the CLEFT-Q show that the CLEFT-Q scores relatively good for all available measurement properties, making it suitable for immediate use. The CLEFT-Q was found to be the only valid instrument so far to measure the impact of orthognathic surgery on the quality of life in patients with cleft deformities.

1 March 2022 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Open access
SWSamuel H. Willemse
Samuel H. Willemse
WSWillem H. Schreuder
Willem H. Schreuder
RARuben C. Apperloo
Ruben C. Apperloo
JLJerôme A.H. Lindeboom
Jerôme A.H. Lindeboom
Information on long-term treatment outcome for nontuberculous mycobacterial (NTM) cervicofacial lymphadenitis in children is scarce. The purpose of this study is to evaluate long-term outcome for surgical treatment, which is the mainstay treatment modality. This case series describes recurrence rates of surgically treated NTM cervicofacial lymphadenitis patients with a follow-up of at least 10 years. The current study data were partially collected from a randomized, prospective, multicenter, multidisciplinary trial (CHIMED study), which was conducted between 2000 and 2006 to determine the optimal treatment for NTM cervicofacial lymphadenitis in children. After the CHIMED trial inclusion ended, our institute continued to serve as a referral center. This enabled us to enlarge the surgical CHIMED cohort by adding patients who were treated during 2007 to 2010 in our center and collect the rest of the current study data. About 427 children with chronic cervicofacial lymphadenopathy were analyzed. Among these, 290 had microbiologically confirmed cervicofacial mycobacterial infections (n = 3 Mycobacterium tuberculosis, n = 1 Mycobacterium bovis, n = 286 NTM). Of these 286 children with NTM cervicofacial lymphadenitis, 189 were treated surgically (median age: 41 months, range: 9-144, 46.0% males). The affected lymph nodes were excised in 151 children (79.9%), and curettage was performed in 38 children (20.1%). One patient (0.07%) experienced a reactivation/recurrence 2 years after surgical excision and required another surgical excision. Three children (7.9%) experienced infection reactivation/recurrences after curettage, confirmed by redness or a draining fistula, within the first year after healing. Two of these 3 patients were treated with additional surgical excisions. The long-term outcome of surgical excision for NTM cervicofacial lymphadenitis is favorable with a low recurrence rate. Curettage or a conservative wait-and-see approach can be considered an alternative in advanced and surgically challenging cases. However, healing will take longer, and late recurrences are possible.

27 January 2023 in Journal of Pediatric Surgery
Verified
Journal Article
Open access
SWSamuel H. Willemse
Samuel H. Willemse
JLJerome A. Lindeboom
Jerome A. Lindeboom
LKLuc He. Karssemakers
Luc He. Karssemakers
MOMarjolijn Aem. Oomens
Marjolijn Aem. Oomens
WSWillem H. Schreuder
Willem H. Schreuder
JLJan de Lange
Jan de Lange

1 November 2020 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
SWS.H. Willemse
S.H. Willemse
LKL.H.E. Karssemakers
L.H.E. Karssemakers
MOM.A.E.M. Oomens
M.A.E.M. Oomens
WSW.H. Schreuder
W.H. Schreuder
JLJ.A. Lindeboom
J.A. Lindeboom
JLJ. de Lange
J. de Lange

26 June 2024 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Open access
SWSamuel H. Md Willemse
Samuel H. Md Willemse
MOMarjolijn A.E.M. Md Oomens
Marjolijn A.E.M. Md Oomens
LKLuc H.E. Md Karssemakers
Luc H.E. Md Karssemakers
JLJerôme A.H. Lindeboom
Jerôme A.H. Lindeboom
WSWillem H. Md Schreuder
Willem H. Md Schreuder
JLJan De Lange
Jan De Lange
A multicenter cross-sectional diagnostic study was carried out including 45 children with nontuberculous mycobacterial cervicofacial lymphadenitis and controls. The tested immunoassay, detecting M. avium–specific anti-glycopeptidolipid-core immunoglobulin A antibodies, had inadequate diagnostic performance in the studied population and seems to be of no additional value in detecting cases of nontuberculous mycobacterial cervicofacial lymphadenitis.